RaineyD.K.Evidence for the anti-inflammatory activity of nedocromil sodium. Clin Exp Allergy1992; 22: 976–9.
2.
KempJ.P.Nedocromil sodium: A new bronchial anti-inflammatory agent. Today's Ther Trends1992; 10: 39–48.
3.
CallaghanB., TeoN.C., ClancyL.Effects of the addition of nedocromil sodium to maintenance bronchodilator therapy in the management of chronic asthma. Chest1992; 101: 787–92.
4.
CherniackR.M., WassermanS.I., RamsdellJ.W., (North American Tilade Study Group) A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. Chest1990; 97: 1299–1306.
5.
BergmannK-Ch, BauerC.P., OverlackA.A placebo-controlled, blind comparison of nedocromil sodium and beclomethasone dipropionate in bronchial asthma. Curr Med Res Opin1989; 11: 533–42.
6.
CrimiE., De BenedettoF., GrassiV.Nedocromil sodium vs. theophylline in the treatment of bronchial asthma. Allergy Clin Immunol News Suppl1991; 1: 328.
7.
MarcouxJ.P., FindlayS.R., FurukawaC.T.A placebo-controlled comparison of nedocromil sodium (TILADE®) and salbutamol in mild to moderate asthma. Eur Respir J1992; 5: 82s.
8.
OreficeU., StruzzoP., DorigoR.Long-term treatment with sodium cromoglycate, nedocromil sodium and beclomethasone dipropionate reduces bronchial hyperresponsiveness in asthmatic subjects. Respiration1992; 59: 97–101.
